Variant report
Variant | nsv522328 |
---|---|
Chromosome Location | chr4:21083553-21096827 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs563886276 | chr4:21083855-21083856 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs575979142 | chr4:21083866-21083867 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs573571037 | chr4:21083939-21083940 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs10017733 | chr4:21083972-21083973 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs189038226 | chr4:21083975-21083976 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs6821010 | chr4:21083978-21083979 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs555714542 | chr4:21083989-21083990 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs180830260 | chr4:21084078-21084079 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs151062105 | chr4:21084152-21084153 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs141312413 | chr4:21084185-21084186 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs536569371 | chr4:21084237-21084238 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs550327718 | chr4:21084263-21084264 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs116125058 | chr4:21084273-21084274 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs62293805 | chr4:21084275-21084276 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs575561901 | chr4:21084283-21084284 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs537394735 | chr4:21084308-21084309 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs186070295 | chr4:21084319-21084320 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs375919635 | chr4:21084340-21084341 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs191412953 | chr4:21084355-21084356 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs145100674 | chr4:21084360-21084361 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs534684808 | chr4:21084361-21084362 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs564241953 | chr4:21084369-21084370 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs138932192 | chr4:21084395-21084396 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs182555362 | chr4:21084428-21084429 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs185677444 | chr4:21084482-21084483 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs71182707 | chr4:21084488-21084489 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs370880529 | chr4:21084489-21084490 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs557542170 | chr4:21084491-21084492 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs575757904 | chr4:21084493-21084494 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs140567993 | chr4:21084496-21084497 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs190584820 | chr4:21084501-21084502 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs71894972 | chr4:21084526-21084527 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs142490779 | chr4:21084535-21084536 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs397992490 | chr4:21084536-21084537 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs34184352 | chr4:21084564-21084565 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs543246094 | chr4:21084571-21084572 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs11931825 | chr4:21084621-21084622 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs114819566 | chr4:21084624-21084625 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs150469531 | chr4:21084675-21084676 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs564555386 | chr4:21084698-21084699 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs559169344 | chr4:21084699-21084700 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs183112968 | chr4:21084705-21084706 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs543907416 | chr4:21084723-21084724 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs562303842 | chr4:21084737-21084738 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs554868466 | chr4:21084748-21084749 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs529842128 | chr4:21084755-21084756 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs540134091 | chr4:21084766-21084767 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs188981691 | chr4:21084773-21084774 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs111505200 | chr4:21084808-21084809 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs138331827 | chr4:21084810-21084811 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Oral squamous cell carcinoma | 17134496 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 17603634 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Neuroblastoma | 17533364 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Cancer | 21637783 | CNVD |
Melanoma | 21693616 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Cervical cancer | 21062161 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Neuroblastoma | 18923191 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Breast cancer | 21785460 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21858162 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Cancer | 21183584 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
Breast cancer | 17133270 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Melanoma | 22183965 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Prostate cancer | 18632612 | CNVD |
Ovarian cancer | 17908972 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Burkitt''s lymphoma | 20823134 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Breast cancer | 22522925 | CNVD |
Breast cancer | 22737080 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Cancer | 20164919 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:21083800-21085200 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
2 | chr4:21084600-21085800 | Enhancers | HUES64 Cell Line | embryonic stem cell |
3 | chr4:21085000-21085600 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
4 | chr4:21085000-21085800 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
5 | chr4:21085000-21086000 | Enhancers | HUES6 Cell Line | embryonic stem cell |
6 | chr4:21085200-21085600 | Enhancers | H1 Cell Line | embryonic stem cell |
7 | chr4:21085200-21085800 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
8 | chr4:21085200-21085800 | Enhancers | HUES48 Cell Line | embryonic stem cell |
9 | chr4:21085200-21086000 | Enhancers | HUVEC | blood vessel |
10 | chr4:21085400-21085800 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
11 | chr4:21085800-21089800 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
12 | chr4:21086000-21089600 | Weak transcription | HUVEC | blood vessel |
13 | chr4:21089600-21090600 | Enhancers | HUVEC | blood vessel |
14 | chr4:21090800-21091800 | Enhancers | Primary Natural Killer cells fromperipheralblood | blood |
15 | chr4:21090800-21092000 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
16 | chr4:21091200-21092800 | Enhancers | Rectal Mucosa Donor 31 | rectum |